Technical Analysis for PULM - Pulmatrix, Inc.

Grade Last Price % Change Price Change
C 1.89 -0.01% 0.00
PULM closed down 0.01 percent on Wednesday, May 8, 2024, on 21 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
Earnings due: May 10
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Down

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
Gapped Up Strength 0.00%
20 DMA Resistance Bearish -0.01%
Crossed Above 50 DMA Bullish -0.01%
Fell Below 50 DMA Bearish 1.61%
Gapped Down Weakness 1.61%
Fell Below 20 DMA Bearish -3.58%
Fell Below 200 DMA Bearish -3.58%
Inside Day Range Contraction -3.58%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 11 hours ago
Gap Up Closed about 12 hours ago
Reversed from Up about 12 hours ago
Gap Up Partially Closed about 14 hours ago
Gapped Up (Partial) about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its iSPERSE technology. The company's proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease and other treatments. Pulmatrix, Inc. is based in Lexington, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Clinical Development Rare Diseases Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis Cystic Fibrosis Pulmonary Disease Pulmonary Fibrosis Pulmonology Treatment Of Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Pulmonary Rehabilitation

Is PULM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.979
52 Week Low 1.55
Average Volume 14,389
200-Day Moving Average 2.01
50-Day Moving Average 1.88
20-Day Moving Average 2.00
10-Day Moving Average 1.94
Average True Range 0.13
RSI (14) 47.09
ADX 17.04
+DI 19.21
-DI 16.24
Chandelier Exit (Long, 3 ATRs) 1.82
Chandelier Exit (Short, 3 ATRs) 2.18
Upper Bollinger Bands 2.18
Lower Bollinger Band 1.82
Percent B (%b) 0.19
BandWidth 17.62
MACD Line 0.00
MACD Signal Line 0.03
MACD Histogram -0.022
Fundamentals Value
Market Cap 6.9 Million
Num Shares 3.65 Million
EPS -4.44
Price-to-Earnings (P/E) Ratio -0.43
Price-to-Sales 0.94
Price-to-Book 0.32
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.04
Resistance 3 (R3) 2.04 2.00 2.01
Resistance 2 (R2) 2.00 1.96 1.99 2.01
Resistance 1 (R1) 1.94 1.93 1.92 1.94 2.00
Pivot Point 1.90 1.90 1.89 1.89 1.90
Support 1 (S1) 1.84 1.86 1.82 1.84 1.78
Support 2 (S2) 1.80 1.83 1.80 1.77
Support 3 (S3) 1.74 1.80 1.77
Support 4 (S4) 1.74